Table 5.
Summary of multivariate analysis in all patients without neoadjuvant chemotherapy showing the odds ratio (95% confidence interval) of variables significantly associated with PD-L1 scoring methods and sTIL level
| Factor | TC | TCIC | IC | sTIL level |
|---|---|---|---|---|
| Age | ||||
| ≥ 50 vs. < 50 years | 0.50 (0.27, 0.92)a | |||
| Race/ethnicity | ||||
| White+Latino vs. Black | 0.32 (0.14, 0.74)b | 0.21 (0.09, 0.53)c | ||
| Others vs. Black | NS | NS | ||
| Histologic grade | ||||
| 3 vs. 1 + 2 | 3.31 (1.38,7.93)b | 4.69 (2.57, 8.57)c | ||
| sTIL level | ||||
| ≥ 10% vs. < 10% | 3.48 (1.50, 8.11)b | 12.44 (6.59, 23.49)c | 23.12 (10.60, 50.42)c | |
| Receptor group | ||||
| ER/PR pos vs. TNBC | 0.20 (0.10, 0.43)c | |||
| HER2 vs. TNBC | NS | |||
NS not significant
aP value < 0.05–0.01
bP value < 0.01–0.001
cP value < 0.001